Form 8-K - Current report:
SEC Accession No. 0001513162-22-000148
Filing Date
2022-12-16
Accepted
2022-12-16 16:35:24
Documents
13
Period of Report
2022-12-16
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 FORM 8-K bmra-20221216.htm   iXBRL 8-K 27077
  Complete submission text file 0001513162-22-000148.txt   162187

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bmra-20221216.xsd EX-101.SCH 3179
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT bmra-20221216_def.xml EX-101.DEF 10555
4 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT bmra-20221216_lab.xml EX-101.LAB 19915
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bmra-20221216_pre.xml EX-101.PRE 10917
7 EXTRACTED XBRL INSTANCE DOCUMENT bmra-20221216_htm.xml XML 2443
Mailing Address 17571 VON KARMAN AVENUE IRVINE CA 92614
Business Address 17571 VON KARMAN AVENUE IRVINE CA 92614 9496452111
BIOMERICA INC (Filer) CIK: 0000073290 (see all company filings)

EIN.: 952645573 | State of Incorp.: DE | Fiscal Year End: 0531
Type: 8-K | Act: 34 | File No.: 001-37863 | Film No.: 221468435
SIC: 2835 In Vitro & In Vivo Diagnostic Substances